CoreAge Rx vs CoraDoc
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and CoraDoc head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make CoraDoc a bad call — it's best for readers who prefer authorizing a new program themselves and can obtain the full payment and controlling refund policy before buying. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | CoraDoc |
|---|---|---|
| Brief Score | 94/100 (A) | 71/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm full program payment Advertised $77/mo equivalent requires a 12-month plan; confirm the full payment and supplied weeks. Clinical-decline refund terms conflict. Full price detailsCompounded semaglutide offered; complete program payment unknown; current $77/month equivalent requires a 12-month plan; earlier listing: From $99/mo (all doses, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm full program payment Advertised $127/mo equivalent requires a 12-month plan; confirm the full payment and supplied weeks. Clinical-decline refund terms conflict. Full price detailsCompounded tirzepatide offered; complete program payment unknown; current $127/month equivalent requires a 12-month plan; earlier listing: From $165/mo (all doses, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises all 50 states; confirm medication-specific clinical and pharmacy eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
CoraDoc: The $77/$127 equivalents require a 12-month plan and do not establish the full program charge. Refund policy retains $100 after a medically ineligible consultation, unlike full-refund marketing.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.